vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -38.1%, a 45.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 22.7%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
PRCT vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $76.2M |
| Net Profit | $-31.6M | $5.6M |
| Gross Margin | 64.9% | 57.9% |
| Operating Margin | -4.1% | 11.0% |
| Net Margin | -38.1% | 7.4% |
| Revenue YoY | 20.2% | 25.5% |
| Net Profit YoY | -27.9% | 30.7% |
| EPS (diluted) | $-0.56 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $76.2M | ||
| Q3 25 | $83.3M | $71.9M | ||
| Q2 25 | $79.2M | $63.1M | ||
| Q1 25 | $69.2M | $59.1M | ||
| Q4 24 | $68.2M | $60.7M | ||
| Q3 24 | $58.4M | $58.0M | ||
| Q2 24 | $53.4M | $55.0M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $5.6M | ||
| Q3 25 | $-21.4M | $3.5M | ||
| Q2 25 | $-19.6M | $3.2M | ||
| Q1 25 | $-24.7M | $2.6M | ||
| Q4 24 | $-18.9M | $4.3M | ||
| Q3 24 | $-21.0M | $3.9M | ||
| Q2 24 | $-25.6M | $1.5M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | 57.9% | ||
| Q3 25 | 64.8% | 57.5% | ||
| Q2 25 | 65.4% | 58.3% | ||
| Q1 25 | 63.9% | 56.3% | ||
| Q4 24 | 64.0% | 59.5% | ||
| Q3 24 | 63.2% | 59.3% | ||
| Q2 24 | 59.0% | 59.8% |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 11.0% | ||
| Q3 25 | -27.8% | 7.8% | ||
| Q2 25 | -28.0% | 8.1% | ||
| Q1 25 | -39.7% | 6.5% | ||
| Q4 24 | -28.9% | 10.6% | ||
| Q3 24 | -38.4% | 9.7% | ||
| Q2 24 | -50.3% | 6.6% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 7.4% | ||
| Q3 25 | -25.7% | 4.9% | ||
| Q2 25 | -24.7% | 5.0% | ||
| Q1 25 | -35.8% | 4.4% | ||
| Q4 24 | -27.6% | 7.1% | ||
| Q3 24 | -35.9% | 6.7% | ||
| Q2 24 | -48.0% | 2.7% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $0.14 | ||
| Q3 25 | $-0.38 | $0.09 | ||
| Q2 25 | $-0.35 | $0.08 | ||
| Q1 25 | $-0.45 | $0.06 | ||
| Q4 24 | $-0.34 | $0.10 | ||
| Q3 24 | $-0.40 | $0.10 | ||
| Q2 24 | $-0.50 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $13.5M |
| Total DebtLower is stronger | $51.7M | — |
| Stockholders' EquityBook value | $347.7M | $141.5M |
| Total Assets | $487.1M | $199.2M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $13.5M | ||
| Q3 25 | $294.3M | $11.1M | ||
| Q2 25 | $302.7M | $20.0M | ||
| Q1 25 | $316.2M | $10.2M | ||
| Q4 24 | $333.7M | $17.5M | ||
| Q3 24 | $196.8M | $11.3M | ||
| Q2 24 | $214.1M | $8.8M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $141.5M | ||
| Q3 25 | $380.3M | $133.6M | ||
| Q2 25 | $385.8M | $139.7M | ||
| Q1 25 | $389.2M | $134.8M | ||
| Q4 24 | $402.2M | $131.4M | ||
| Q3 24 | $241.2M | $125.0M | ||
| Q2 24 | $251.8M | $119.4M |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $199.2M | ||
| Q3 25 | $511.5M | $202.4M | ||
| Q2 25 | $513.1M | $184.6M | ||
| Q1 25 | $519.4M | $178.1M | ||
| Q4 24 | $534.0M | $177.1M | ||
| Q3 24 | $374.1M | $169.5M | ||
| Q2 24 | $374.4M | $163.9M |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $18.4M | ||
| Q3 25 | $-6.6M | $18.4M | ||
| Q2 25 | $-15.0M | $12.3M | ||
| Q1 25 | $-17.0M | $2.9M | ||
| Q4 24 | $-32.4M | $15.0M | ||
| Q3 24 | $-18.8M | $12.7M | ||
| Q2 24 | $-15.7M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $9.7M | ||
| Q3 25 | $-9.5M | $10.7M | ||
| Q2 25 | $-17.8M | $4.1M | ||
| Q1 25 | $-18.8M | $-12.6M | ||
| Q4 24 | $-33.6M | $3.2M | ||
| Q3 24 | $-19.0M | $1.7M | ||
| Q2 24 | $-16.8M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 12.7% | ||
| Q3 25 | -11.4% | 14.9% | ||
| Q2 25 | -22.5% | 6.5% | ||
| Q1 25 | -27.2% | -21.4% | ||
| Q4 24 | -49.2% | 5.2% | ||
| Q3 24 | -32.6% | 3.0% | ||
| Q2 24 | -31.4% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 11.5% | ||
| Q3 25 | 3.4% | 10.6% | ||
| Q2 25 | 3.5% | 12.9% | ||
| Q1 25 | 2.7% | 26.2% | ||
| Q4 24 | 1.7% | 19.5% | ||
| Q3 24 | 0.4% | 19.0% | ||
| Q2 24 | 2.0% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
VMD
Segment breakdown not available.
